caa a22 4500 386346615 CHVBK 20180307111813.0 cr unu---uuuuu 161130e198909 xx s 000 0 eng 10.1017/S0022215100110308 doi S0022215100110308 pii (NATIONALLICENCE)cambridge-10.1017/S0022215100110308 Clofazimin in the treatment of scleroma [Elektronische Daten] Scleroma is a chronic progressive granulomatous disease predominantly affecting the mucous membrane of the upper respiratory tract, endemic in temperate and tropical zone countries including Egypt. Many patients in early stages respond to medical treatment while others do not. In these patients an antileprotic agent Clofazimin (Lamprene®) was tried in 76 patients and the therapeutic results are very promising, especially for the early stages of the disease. Copyright © JLO (1984) Limited 1989 Shehata M. A. Departments of Ear, Nose and Throat and Radiation Oncology, Faculty of Medicine, University of Alexandria, Egypt Salama A. M. Departments of Ear, Nose and Throat and Radiation Oncology, Faculty of Medicine, University of Alexandria, Egypt The Journal of Laryngology & Otology Cambridge University Press 103/9(1989-09), 856-860 0022-2151 103:9<856 1989 103 JLO https://doi.org/10.1017/S0022215100110308 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1017/S0022215100110308 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Shehata M. A. Departments of Ear, Nose and Throat and Radiation Oncology, Faculty of Medicine, University of Alexandria, Egypt NATIONALLICENCE 700 1- Salama A. M. Departments of Ear, Nose and Throat and Radiation Oncology, Faculty of Medicine, University of Alexandria, Egypt NATIONALLICENCE 773 0- The Journal of Laryngology & Otology Cambridge University Press 103/9(1989-09), 856-860 0022-2151 103:9<856 1989 103 JLO CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-cambridge